Non-Interventional Studies: building and broadening the value story

What is the utility of observational data? How does it differ from data collected under experimental conditions such as randomized controlled trials (RCTs)? Does it have any other value than optimizing market access in pharma companies?

MS Teams

SPARK Europe Webinar Series ǀ 7 September 2022 | 4 - 5 pm (CET)
Daniel Schwarz & Marika Chrápavá  “Non-Interventional Studies: building and broadening the value story”

What is the utility of observational data? How does it differ from data collected under experimental conditions such as randomized controlled trials (RCTs)? Does it have any other value than optimizing market access in pharma companies?

Online via MS Teams ǀ Please register here!

Registration to the webinar is required in advance.

This webinar will be hosted by SPARK at the Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Contact:
Dr. Vera Martos Riaño
vera.martos-riano@bihealth.de

SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.

SPARK-BIH is a member of the SPARK Global network